Trademark: 87748724
Status Date
Tuesday, January 4, 2022
Registration Number
6608643
Registration Date
Tuesday, January 4, 2022
Filing Date
Tuesday, January 9, 2018
Published for Opposition
Tuesday, September 11, 2018
42 Pharmaceutical research and drug development; medical and scientific research, namely, conducting clinical trials for others; development of pharmaceuticals for the treatment of infectious, viral, inflammatory, immunological, autoimmune and cardiovascular diseases and disorders; development of pharmaceuticals for the treatment of cancer, namely, cancers of the immune system such as T-cell and B-cell leukemias and lymphomas; development of pharmaceuticals for the treatment of influenza, AIDS, SARS, Ebola, Zika, and West Nile virus; development of pharmaceuticals for the treatment of hereditary angioedema, inflammatory bowel diseases, inflammatory connective tissue diseases and inflammatory skin diseases
The mark consists of a stylized shaded diamond with the left and right corners rounded inward and connected by an unshaded line extending from the midpoint of each curved edge, with several unshaded circles contained inside the diamond at the top and bottom corners.
Color is not claimed as a feature of the mark.
May 3, 2023
Assignment Of Ownership Not Updated Automatically
Jan 4, 2022
Registered-Principal Register
Nov 27, 2021
Notice Of Acceptance Of Statement Of Use E-Mailed
Nov 26, 2021
Allowed Principal Register - Sou Accepted
Nov 5, 2021
Statement Of Use Processing Complete
Nov 3, 2021
Use Amendment Filed
Nov 3, 2021
Teas Statement Of Use Received
Jul 21, 2021
Teas Change Of Correspondence Received
Jul 21, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Jul 21, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
May 18, 2021
Notice Of Approval Of Extension Request E-Mailed
May 17, 2021
Sou Extension 5 Granted
May 6, 2021
Sou Extension 5 Filed
May 17, 2021
Case Assigned To Intent To Use Paralegal
May 6, 2021
Teas Extension Received
May 6, 2021
Teas Change Of Correspondence Received
May 6, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
May 6, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 16, 2021
Applicant/Correspondence Changes (Non-Responsive) Entered
Apr 16, 2021
Teas Change Of Correspondence Received
Apr 16, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Apr 16, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 16, 2021
Teas Change Of Owner Address Received
Oct 28, 2020
Notice Of Approval Of Extension Request E-Mailed
Oct 26, 2020
Sou Extension 4 Granted
Oct 26, 2020
Sou Extension 4 Filed
Oct 26, 2020
Teas Extension Received
May 8, 2020
Notice Of Approval Of Extension Request E-Mailed
May 6, 2020
Sou Extension 3 Granted
May 6, 2020
Sou Extension 3 Filed
May 6, 2020
Teas Extension Received
Oct 31, 2019
Notice Of Approval Of Extension Request E-Mailed
Oct 29, 2019
Sou Extension 2 Granted
Oct 29, 2019
Sou Extension 2 Filed
Oct 29, 2019
Teas Extension Received
Apr 30, 2019
Teas Change Of Correspondence Received
May 2, 2019
Notice Of Approval Of Extension Request E-Mailed
Apr 30, 2019
Sou Extension 1 Granted
Apr 30, 2019
Sou Extension 1 Filed
Apr 30, 2019
Teas Extension Received
Nov 6, 2018
Noa E-Mailed - Sou Required From Applicant
Sep 11, 2018
Official Gazette Publication Confirmation E-Mailed
Sep 11, 2018
Published For Opposition
Aug 22, 2018
Notification Of Notice Of Publication E-Mailed
Aug 4, 2018
Approved For Pub - Principal Register
Jul 24, 2018
Teas/Email Correspondence Entered
Jul 24, 2018
Correspondence Received In Law Office
Jul 24, 2018
Assigned To Lie
Jul 12, 2018
Teas Change Of Correspondence Received
Jul 11, 2018
Teas Response To Office Action Received
Jul 11, 2018
Teas Change Of Correspondence Received
Apr 20, 2018
Notification Of Non-Final Action E-Mailed
Apr 20, 2018
Non-Final Action E-Mailed
Apr 20, 2018
Non-Final Action Written
Apr 13, 2018
Assigned To Examiner
Jan 24, 2018
Notice Of Design Search Code E-Mailed
Jan 23, 2018
New Application Office Supplied Data Entered
Jan 12, 2018
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
